Fed. Circ. OKs $12M Fees For Lilly, Elan In IP ‘Conspiracy’

Law360, New York (August 10, 2017, 8:49 PM EDT) -- The Federal Circuit on Thursday rejected Alzheimer's Institute of America Inc.’s argument that only juries can award attorneys’ fees in patent cases, affirming $12 million in fee awards against the company after finding it obtained patents asserted against Eli Lilly and Elan through a “conspiracy.”

The appeals court previously affirmed a decision that the institute appropriated inventions related to Alzheimer’s diagnosis from others, then accused Eli Lilly & Co. and Elan Pharmaceuticals Inc. of infringing, a scheme a lower court said was “motivated by ego and...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

AIA America, Inc. v. Eli Lilly & Company


Case Number

16-2094

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

May 18, 2016


Case Title

AIA America, Inc. v. Avid Radiopharmaceuticals


Case Number

16-2647

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

September 16, 2016

Law Firms

Companies

Patents

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.